EXPRESS: Novel dose-response analyses of treprostinil in pulmonary arterial hypertension and its effects on 6-minute walk distance and hospitalizations:

Treprostinil is a prostacyclin analogue approved for the treatment of pulmonary arterial hypertension. Apart from the inhaled formulation, there is neither a target dose nor a ceiling dose to guide...